A Phase 2 Evaluation of the Safety, Ocular Tolerability, and Efficacy of Topical Ophthalmic BL1107 Versus Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Recruiting
Location: See all (14) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Ocular hypertension or primary open-angle glaucoma in each eye
Locations
United States
California
Global Research Management, Inc.
RECRUITING
Glendale
Eye Research Foundation
RECRUITING
Newport Beach
California Eye Specialist Medical Group, LLC
RECRUITING
Pasadena
Florida
Eye Associates of Fort Myers
RECRUITING
Fort Myers
Levenson Eye Associates
RECRUITING
Jacksonville
Central Florida Eye Associates
RECRUITING
Lakeland
Lee Shettle Eye and Hearing
RECRUITING
Largo
Georgia
Clayton Eye Clinical Research, LLC
RECRUITING
Morrow
Coastal Research Associates, LLC
RECRUITING
Roswell
Kansas
Heart of America Eye Care
RECRUITING
Shawnee Mission
Massachusetts
Andover Eye Associates
RECRUITING
Andover
Pennsylvania
Scott & Christie and Associates, PC
RECRUITING
Cranberry Township
Tennessee
Total Eye Care, P.A.
RECRUITING
Memphis
Texas
Houston Eye Associates
RECRUITING
Houston
Contact Information
Primary
Johnson Varughese
Johnson.Varughese@bausch.com
9089271162
Time Frame
Start Date: 2025-10-24
Estimated Completion Date: 2026-05
Participants
Target number of participants: 228
Treatments
Experimental: BL1107 Low dose
Experimental: BL1107 High dose
Active_comparator: Timolol maleate 0.5%
Related Therapeutic Areas
Sponsors
Leads: Bausch & Lomb Incorporated